Your browser doesn't support javascript.
loading
High-titer neutralization of Mu and C.1.2 SARS-CoV-2 variants by vaccine-elicited antibodies of previously infected individuals.
Tada, Takuya; Zhou, Hao; Dcosta, Belinda M; Samanovic, Marie I; Cornelius, Amber; Herati, Ramin S; Mulligan, Mark J; Landau, Nathaniel R.
Affiliation
  • Tada T; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.
  • Zhou H; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.
  • Dcosta BM; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA.
  • Samanovic MI; NYU Langone Vaccine Center and Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
  • Cornelius A; NYU Langone Vaccine Center and Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
  • Herati RS; NYU Langone Vaccine Center and Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
  • Mulligan MJ; NYU Langone Vaccine Center and Department of Medicine, NYU Grossman School of Medicine, New York, NY, USA.
  • Landau NR; Department of Microbiology, NYU Grossman School of Medicine, New York, NY, USA. Electronic address: nathaniel.landau@med.nyu.edu.
Cell Rep ; 38(2): 110237, 2022 01 11.
Article de En | MEDLINE | ID: mdl-34982967
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anticorps neutralisants / Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Anticorps antiviraux Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Anticorps neutralisants / Vaccins contre la COVID-19 / SARS-CoV-2 / COVID-19 / Anticorps antiviraux Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Cell Rep Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique